GB9615767D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9615767D0
GB9615767D0 GBGB9615767.2A GB9615767A GB9615767D0 GB 9615767 D0 GB9615767 D0 GB 9615767D0 GB 9615767 A GB9615767 A GB 9615767A GB 9615767 D0 GB9615767 D0 GB 9615767D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9615767.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9615767.2A priority Critical patent/GB9615767D0/en
Publication of GB9615767D0 publication Critical patent/GB9615767D0/en
Priority to NZ333813A priority patent/NZ333813A/xx
Priority to PCT/EP1997/004159 priority patent/WO1998004289A2/en
Priority to CZ99237A priority patent/CZ23799A3/cs
Priority to AU42972/97A priority patent/AU725817B2/en
Priority to KR1019997000622A priority patent/KR20000029564A/ko
Priority to JP10508522A priority patent/JP2000516924A/ja
Priority to IL12821997A priority patent/IL128219A0/xx
Priority to CA002261813A priority patent/CA2261813A1/en
Priority to HU9903619A priority patent/HUP9903619A3/hu
Priority to BR9710568A priority patent/BR9710568A/pt
Priority to CN97197977A priority patent/CN1230894A/zh
Priority to PL97331426A priority patent/PL331426A1/xx
Priority to TR1999/00140T priority patent/TR199900140T2/xx
Priority to EP97918947A priority patent/EP0936924A2/en
Priority to ARP970103348A priority patent/AR008083A1/es
Priority to ZA976593A priority patent/ZA976593B/xx
Priority to CO97042582A priority patent/CO5031292A1/es
Priority to NO990322A priority patent/NO990322L/no
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9615767.2A 1996-07-26 1996-07-26 Novel treatment Pending GB9615767D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment
EP97918947A EP0936924A2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht 2c? antagonist and a d 2? antagonist
CA002261813A CA2261813A1 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
BR9710568A BR9710568A (pt) 1996-07-26 1997-07-22 Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2
CZ99237A CZ23799A3 (cs) 1996-07-26 1997-07-22 Farmaceutický přípravek obsahující 5HT2C antagonistu a D2 antagonistu
AU42972/97A AU725817B2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5HT2c antagonist and a D2 antagonist
KR1019997000622A KR20000029564A (ko) 1996-07-26 1997-07-22 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물
JP10508522A JP2000516924A (ja) 1996-07-26 1997-07-22 ５ｈｔ▲下２ｃ▼アンタゴニストおよびｄ▲下２▼アンタゴニストを含む医薬組成物
IL12821997A IL128219A0 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
NZ333813A NZ333813A (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5HT2C antagonist and a D2 antagonist
HU9903619A HUP9903619A3 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
PCT/EP1997/004159 WO1998004289A2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
CN97197977A CN1230894A (zh) 1996-07-26 1997-07-22 含有5HT2c拮抗剂和D2拮抗剂的药物组合物
PL97331426A PL331426A1 (en) 1996-07-26 1997-07-22 Pharmaceutic composition containing the 5ht2c antagonist and the d2 antagonist
TR1999/00140T TR199900140T2 (xx) 1996-07-26 1997-07-22 5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi.
ZA976593A ZA976593B (en) 1996-07-26 1997-07-24 Novel treatment
ARP970103348A AR008083A1 (es) 1996-07-26 1997-07-24 Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc.
CO97042582A CO5031292A1 (es) 1996-07-26 1997-07-25 Nuevo tratamiento
NO990322A NO990322L (no) 1996-07-26 1999-01-25 Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment

Publications (1)

Publication Number Publication Date
GB9615767D0 true GB9615767D0 (en) 1996-09-04

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9615767.2A Pending GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment

Country Status (19)

Country Link
EP (1) EP0936924A2 (xx)
JP (1) JP2000516924A (xx)
KR (1) KR20000029564A (xx)
CN (1) CN1230894A (xx)
AR (1) AR008083A1 (xx)
AU (1) AU725817B2 (xx)
BR (1) BR9710568A (xx)
CA (1) CA2261813A1 (xx)
CO (1) CO5031292A1 (xx)
CZ (1) CZ23799A3 (xx)
GB (1) GB9615767D0 (xx)
HU (1) HUP9903619A3 (xx)
IL (1) IL128219A0 (xx)
NO (1) NO990322L (xx)
NZ (1) NZ333813A (xx)
PL (1) PL331426A1 (xx)
TR (1) TR199900140T2 (xx)
WO (1) WO1998004289A2 (xx)
ZA (1) ZA976593B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
JP2002530341A (ja) 1998-11-23 2002-09-17 セプラコール， インク． デスメチルオランザピン組成物及び方法
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
JP2002530340A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． オランザピン−ｎ−オキサイドを含む医薬組成物
EP1165090A2 (en) * 1999-03-18 2002-01-02 Children's Hospital Research Foundation A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
WO2000071106A2 (en) * 1999-05-19 2000-11-30 Astrazeneca Ab Method of treating weight gain
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
JP2000516924A (ja) 2000-12-19
PL331426A1 (en) 1999-07-19
AU4297297A (en) 1998-02-20
CN1230894A (zh) 1999-10-06
AR008083A1 (es) 1999-12-09
HUP9903619A2 (hu) 2000-10-28
HUP9903619A3 (en) 2001-03-28
NZ333813A (en) 2000-07-28
EP0936924A2 (en) 1999-08-25
ZA976593B (en) 1999-01-25
CZ23799A3 (cs) 1999-06-16
CO5031292A1 (es) 2001-04-27
KR20000029564A (ko) 2000-05-25
TR199900140T2 (xx) 1999-03-22
NO990322L (no) 1999-03-24
NO990322D0 (no) 1999-01-25
WO1998004289A2 (en) 1998-02-05
AU725817B2 (en) 2000-10-19
IL128219A0 (en) 1999-11-30
CA2261813A1 (en) 1998-02-05
WO1998004289A3 (en) 1998-03-19
BR9710568A (pt) 1999-08-17

Similar Documents

Publication Publication Date Title
GB9411080D0 (en) Treatment
GB9700899D0 (en) Novel treatment
GB9519033D0 (en) Treatment
GB9619492D0 (en) Novel treatment
GB9410512D0 (en) Novel treatment
GB9615767D0 (en) Novel treatment
GB9411635D0 (en) Novel treatment
GB9608657D0 (en) Novel treatment
GB2355006B (en) Materials treatment
GB9625795D0 (en) Novel treatment
GB9612752D0 (en) Novel treatment
GB9620085D0 (en) Cosmetic treatment
GB9721692D0 (en) Novel treatment
GB9614739D0 (en) Novel treatment
GB9616413D0 (en) Novel treatment
GB9614751D0 (en) Novel treatment
GB9616409D0 (en) Novel treatment
GB9616410D0 (en) Novel treatment
GB9619073D0 (en) Novel treatment
GB9616415D0 (en) Novel treatment
GB9616408D0 (en) Novel treatment
GB9604046D0 (en) Novel treatment
GB9616414D0 (en) Novel treatment
GB9616412D0 (en) Novel treatment
GB9625201D0 (en) Novel treatment